MEC Plus

Novel Frontiers in the Use of ctDNA in Oncology
Novel Frontiers in the Use of ctDNA in Oncology
Christian Rolfo, MD, PhD, MBA, Dr.hc
New Developments in Therapeutics for Metastatic Breast Cancer
New Developments in Therapeutics for Metastatic Breast Cancer
Mohammad Jahanzeb, MD, FACP, FASCO
New Developments in CLL
New Developments in CLL
Javier Pinilla-Ibarz, MD, PhD
Most Relevant News in Multiple Myeloma in 2021
Most Relevant News in Multiple Myeloma in 2021
Sikander Ailawadhi, MD
Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC
Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC
Luis E. Raez, MD, FACP, FCCP
Modern Challenges and new options for B-cell NHL
Modern Challenges and new options for B-cell NHL
Eduardo Sotomayor, MD
Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations
Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations
Alexander B. Olawaiye, MD
Breast Cancer Update in Hormone Sensitive Breast Cancer
Breast Cancer Update in Hormone Sensitive Breast Cancer
Ingrid A. Mayer, MD, MSCI
Advances in Targeted Therapy in Lung Cancer
Advances in Targeted Therapy in Lung Cancer
Edgardo S. Santos, MD, FACP
Advances in Head and Neck Cancers Including Thyroid Malignancies
Advances in Head and Neck Cancers Including Thyroid Malignancies
Tanguy Seiwert, MD
Immunotherapy Session
Immunotherapy Session
Sanjiv Agarwala, MD; Pedro Barata, MD; Ahmed Zakari, MD; Pedro G. Solivan, MD
Solid Tumors: Gynecology, Prostate & GI Malignancies
Solid Tumors: Gynecology, Prostate & GI Malignancies
Thomas Herzog, MD; Ulka Vaishampayan, MD; Ahmed Zakari, MD
Lung Cancer Session
Lung Cancer Session
Pedro G. Solivan, MD; Edgardo S. Santos Castillero, MD, FACP; Luis E. Raez, MD, FACP, FCCP; Genelis Domingo, MD
Breast Cancer Session
Breast Cancer Session
Vicente Valero, MD; Luis Baez Vallecillo, MD; Noridza Rivera-Rodriguez, MD; Mariana Chavez-MacGregor, MD; Mohammad Jahanzeb, MD, FACP, FASCO
Managing Symptoms & Supportive Care
Managing Symptoms & Supportive Care
Jorge J. García, PharmD, MS, MHA, MBA, FACHE; Rosanna Rodriguez, PA-C; Mildred Flores, RN, PhD
Lung Targeted Therapies IN NSCLC: EGFR, ALK, and ROS1
Lung Targeted Therapies IN NSCLC: EGFR, ALK, and ROS1
Edgardo S. Santos, MD, FACP
Lung Targeted Therapies in NSCLC: RET, MET and EGFR/HER-2 exon 20
Lung Targeted Therapies in NSCLC: RET, MET and EGFR/HER-2 exon 20
Robert Ramirez, DO, FACP
Immunotherapy & Targeted Therapy in Melanoma
Immunotherapy & Targeted Therapy in Melanoma
Sanjiv Agarwala, MD
Immunotherapy in Lung
Immunotherapy in Lung
Luis E. Raez, MD, FACP, FCCP
Breast Targeted Therapy:  HER2, CDK 4/6, PI3KCA
Breast Targeted Therapy: HER2, CDK 4/6, PI3KCA
Mark Pegram, MD
MEDPRO™ Talk: A Patient’s Perspective
MEDPRO™ Talk: A Patient’s Perspective
Shannon Baxter, PhD
Immunotherapy in Breast
Immunotherapy in Breast
Alberto Montero, MD, MBA, CPHQ
Immunotherapy in Kidney & Bladder
Immunotherapy in Kidney & Bladder
Pedro Barata, MD, MSc
Targeted Therapy in Prostate
Targeted Therapy in Prostate
Ulka Vaishampayan, MD